SCHEMBL8034797

SCHEMBL8034797

COC(=O)CN1CCC(N2CCN(c3ccc(C(=N)NO)cc3)C(=O)C2)CC1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
ALOX15 P16050 1/20 0.43
HRH3 Q9Y5N1 9/20 0.37
KCNH2 Q12809 4/20 0.35
HRH1 P35367 1/20 0.35
TACR1 P25103 1/20 0.35
MTOR P42345 1/20 0.34
HDAC1 Q13547 2/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
ABL1 P00519 1/20 0.33
EGFR P00533 1/20 0.33
LCK P06239 1/20 0.33
SRC P12931 1/20 0.33
ABL2 P42684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8044034 0.92 ITGB3 (0.42) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8034391 0.91 ITGB3 (0.43) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8045526 0.89 ITGB3 (0.56) ITGB3ITGA2BALOX15HRH3KCNH2
Hydrochloric Acid SCHEMBL8043473 0.88 ALOX15 (0.58) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8043708 0.84 ITGB3 (0.41) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8043652 0.82 ITGB3 (0.41) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8052277 0.82 HRH3 (0.44) ITGB3ITGA2BALOX15HRH3KCNH2
SCHEMBL8044020 0.80 ITGB3 (0.55) ITGB3ITGA2BALOX15HRH3
Hydrochloric Acid SCHEMBL8034450 0.79 ALOX15 (0.56) ITGB3ITGA2BALOX15HRH3
SCHEMBL8034558 0.76 ITGB3 (0.74) ITGB3ITGA2BALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057324-A HAVE GPIIB/IIIA RECEPTOR ANTAGONIZING ACTIVITY AND ARE USEFUL FOR AMELIORATING ISCHEMIC CARDIAC DISORDERS, FOR AMELIORATING CEREBROVASCULAR DISORDERS, AND FOR AMELIORATING PERIPHERAL ARTERY DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) 2000-05-02 US disclosed
EP-0905129-A1 SUBSTITUTED AMIDINOBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1999-03-31 EP disclosed